Skip to main content


Science and Law Experts Discuss Marijuana, CBD, and Delta 8

Sep. 28, 2021—Last week I had the pleasure to speak on a panel on the legal and scientific issues surrounding Delta 8 THC, CBD, and marijuana. The panel was organized by Larry Marnett, the Dean of Basic Sciences at Vanderbilt University School of Medicine, and also included Sachin Patel, Professor of Psychiatry at Vanderbilt who researches the...

Read more

New Congressional Farm Bill Legalizes Some Marijuana

Dec. 13, 2018—[Updated 12/21 10:45 am: As expected, President Trump signed the Farm Bill into law on Dec. 20. The Commissioner of the FDA also issued a notable statement on the Bill (h/t to Doug Berman). The Commissioner emphasizes the points I make below regarding the ongoing limitations imposed by the FDCA on the use of CBD...

Read more

Caveat Emptor: Are Marijuana Labels Accurate?

Nov. 15, 2017—As discussed in the book, many legalization states have adopted detailed labeling requirements for marijuana products (see pages 456-462). Among other things, suppliers must clearly indicate the quantity of THC and CBD contained in packages of marijuana. Labeling requirements like these are designed to inform consumers and thereby help them make better consumption choices. To...

Read more

The Odd Legal Status of CBD under Federal Law

Oct. 18, 2017—As discussed in Chapter 4 of the book, much of the controversy surrounding marijuana’s purported benefits and harms has stemmed from THC, the psychoactive cannabinoid commonly found in the cannabis plant. However, another non-psychoactive cannabinoid, cannabidiol (CBD), has been drawing increasing interest, because it purportedly generates its own distinct medical benefits (e.g., in calming seizures) while producing none...

Read more